Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CRT)

LivaNova

Status: Completed

Conditions: Congestive Heart Failure

Treatments: Other: Echocardiography and SonR recording

Study type: Observational

Funder types: Industry

Identifiers

NCT01066078

RGEA01 - CAP PEA

RGEA01

Details and patient eligibility

About

This study used an external endocardial acceleration sensor (sonR sensor), placed on the patient's chest, to time the closure of aortic and mitral valves, and compared its performance with echocardiography.

Enrollment: 216 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Every patient coming in the participating centers for an echocardiographic exam and implanted with a pacemaker or an implantable cardioverter defibrillator (ICD) can be included in the study.

Exclusion criteria

• Inability to understand the patient information sheet.
• Minor patient or pregnant woman.

Trial design

216 participants in 1 patient group

CRT recipients

Treatment:

Other: Echocardiography and SonR recording